Send to

Choose Destination
Hamostaseologie. 2009 Jan;29(1):112-20.

[Pathophysiology of chemotherapy-associated thrombosis].

[Article in German]

Author information

Abteilung für Hämatologie und Hämostaseologie, Universitätsklinik für Innere Medizin I, Medizinische Universität Wien, Osterreich.


Epidemiological studies revealed that most antineoplastic agents and regimes enhance the risk of venous and arterial thromboembolic events in cancer patients. The purpose of this article is to review clinical and pathophysiological data related to chemotherapy-associated thromboembolism under special consideration of newer treatment strategies, such as angiogenesis inhibitors and immunmodulatory agents. Despite numerous clinical and experimental studies it has to be concluded that we are far from a comprehensive understanding of the pathogenesis of chemotherapy-associated thrombosis.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center